SupportLoginSign Up
Featured FeedJournalsCollectionsKeywords
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Keratoelastoidosis marginalis.

Yebabe M Mengesha, John D Kayal, Robert A Swerlick
Journal of Cutaneous Medicine and Surgery 2002 January
BACKGROUND: Keratoelastoidosis marginalis is a rare disease that is a variant of solar elastosis. Long-term ultraviolet radiation exposure and chronic trauma secondary to manual labor are considered to be inciting factors.

OBJECTIVE: To outline the clinical and histological features of this disorder.

METHODS: We report two cases and review the literature.

RESULTS: Both patients had persistence of their disease despite multiple topical treatment regimens.

CONCLUSION: Keratoelastoidosis marginalis is a chronic and progressive disease that is difficult to treat. The differential includes focal acral hyperkeratosis and acrokeratoelastoidosis.

Full text links

Find Full Text Links for this Article

Trending Papers

Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium-Glucose Co-transporter-2 Inhibitors.Joshua J Neumiller et al.TouchREVIEWS in endocrinology. 2022 November
How we treat primary immune thrombocytopenia in adults.Xin-Guang Liu, Yu Hou, Ming HouJournal of Hematology & Oncology 2023 January 20
Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.Nathan I Shapiro et al.New England Journal of Medicine 2023 January 22

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Do Not Sell My Personal InformationManage Cookie Preferences

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app